All In MedTech

FDA Clearance Tracker · P200046

Harmony™ TPV System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Mar 26, 2021 (this decision)Source: openFDAMethods & limitations

PMABreakthrough

Decided

Mar 26, 2021

Approved

Time to decision

128 days

Received Nov 18, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

The decision

FDA number
P200046
Device name
Harmony™ TPV System
Applicant location
Santa Rosa, CA
Received
Nov 18, 2020
Decided
Mar 26, 2021
Decision
Approved
Supplements
51 in FDA's data for this PMA. See them on the FDA record

Device type

Every decision under product code NPV

FDA's approval statement

As written in FDA's record.

Approval for the Harmony™ Transcatheter Pulmonary Valve (TPV) System. This device is indicated for use in the management of pediatric and adult patients with severe pulmonary regurgitation (i.e., severe pulmonary regurgitation as determined by echocardiography and/or pulmonary regurgitant fraction >= 30% as determined by cardiac magnetic resonance imaging) who have a native or surgically-repaired right ventricular outflow tract and are clinically indicated for surgical pulmonary valve replacement.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NPV. The earliest in FDA's data is P140017, decided Jan 27, 2015.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.